Psyence Biomedical Ltd.

NasdaqCM:PBM Stock Report

Market Cap: US$4.1m

Psyence Biomedical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Neil Maresky

Chief executive officer

US$390.0k

Total compensation

CEO salary percentage92.31%
CEO tenure1.5yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Neil Maresky's remuneration changed compared to Psyence Biomedical's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025US$390kUS$360k

US$1m

Dec 31 2024n/an/a

-US$23m

Sep 30 2024n/an/a

-US$47m

Jun 30 2024n/an/a

-US$49m

Mar 31 2024US$357kUS$231k

-US$51m

Dec 31 2023n/an/a

-US$28m

Sep 30 2023n/an/a

-US$4m

Jun 30 2023n/an/a

-US$4m

Mar 31 2023US$311kUS$192k

-US$3m

Compensation vs Market: Neil's total compensation ($USD390.00K) is below average for companies of similar size in the US market ($USD644.39K).

Compensation vs Earnings: Neil's compensation has been consistent with company performance over the past year.

CEO

Neil Maresky (61 yo)

1.5yrs
Tenure
US$390,000
Compensation

Dr. Neil Maresky, M.D., M.B., B.Ch., served as Chief Executive Officer at Psyence Group Inc. since July 1, 2021 until March 2024 and serves as its Director since December 09, 2021. He serves as Chief Execu...

Board Members

NamePositionTenureCompensationOwnership
Jody Aufrichtig
Co-Founder1.5yrsUS$216.67kno data
Neil Maresky
CEO & Director2.1yrsUS$390.00kno data
Dan Stein
Member of Scientific Advisory Boardless than a yearno datano data
Seth Feuerstein
Member of Scientific Advisory Board & Independent Director1.5yrsno datano data
Marc Balkin
Independent Director1.5yrsno datano data
Christopher Bull
Independent Director1.5yrsno datano data
Clive Able
Member of Scientific Advisory Boardless than a yearno datano data
Albert Garcia-Romeu
Chairman of Scientific Advisory Boardless than a yearno datano data
1.5yrs
Average Tenure
52yo
Average Age

Experienced Board: PBM's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/30 08:27
End of Day Share Price 2025/07/30 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Psyence Biomedical Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.